Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty: Complete Statistical AnalysisIndependent statistical analysis of Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD: Complete Statistical AnalysisIndependent statistical analysis of Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD: primary endpoint results, effect estimate with…
- Safety of 4CMenB Exposure During Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Safety of 4CMenB Exposure During Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02640677).
- Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals’ Boostrix™ Vaccine in Healthy Vietnamese Children: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity…
- Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam: primary endpoint results, effect estimate with confidence interval,…
- Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth: Complete Statistical AnalysisIndependent statistical analysis of Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: Complete Statistical AnalysisIndependent statistical analysis of Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04084171).
- Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR: Complete Statistical AnalysisIndependent statistical analysis of Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: Complete Statistical AnalysisIndependent statistical analysis of Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.: Complete Statistical AnalysisIndependent statistical analysis of Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval,…
- Safety of Intravenous Apramycin in Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Apramycin in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05590728).
- Safety of Intravenous Neridronic Acid in CRPS: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Neridronic Acid in CRPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02972359).
- Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.: Complete Statistical AnalysisIndependent statistical analysis of Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03334747).
- Safety of Nerivio in Pregnant Women With Migraine: Complete Statistical AnalysisIndependent statistical analysis of Safety of Nerivio in Pregnant Women With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05464069).
- Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: Complete Statistical AnalysisIndependent statistical analysis of Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: primary endpoint results,…
- Safety of Optimal PEEP in NSICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety of Optimal PEEP in NSICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03862027).
- Safety of RIV4 Versus IIV4 in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Safety of RIV4 Versus IIV4 in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03969641).
- Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection: Complete Statistical AnalysisIndependent statistical analysis of Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145): Complete Statistical AnalysisIndependent statistical analysis of Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145): primary endpoint results, effect estimate with confidence…
- Safety of the Nocturnal Passy Muir Valve and Impact on Sleep Quality at an LTACH Setting: Complete Statistical AnalysisIndependent statistical analysis of Safety of the Nocturnal Passy Muir Valve and Impact on Sleep Quality at an LTACH Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids: Complete Statistical AnalysisIndependent statistical analysis of Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids: primary endpoint results, effect estimate with confidence…
- Safety of Vitamin D Supplementation in Older Persons: Complete Statistical AnalysisIndependent statistical analysis of Safety of Vitamin D Supplementation in Older Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00681590).
- Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study for an All-in-One Body and Personal Lubricant: Complete Statistical AnalysisIndependent statistical analysis of Safety Study for an All-in-One Body and Personal Lubricant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01189617).
- Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif: Complete Statistical AnalysisIndependent statistical analysis of Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01469156).
- Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of a Sensitive Sensual Touch and Personal Lubricant: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of a Sensitive Sensual Touch and Personal Lubricant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01271036).
- Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02100839).
- Safety Study of Airway Clearance Techniques in Infants.: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Airway Clearance Techniques in Infants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02128867).
- Safety Study of Albuterol Spiromax® in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Albuterol Spiromax® in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01698320).
- Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety Study of Cosmetic Tissue Augmentation in People of Color: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Cosmetic Tissue Augmentation in People of Color: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147172).
- Safety Study of CSL Limited’s Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years: primary endpoint results, effect estimate with confidence interval,…
- Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age: primary endpoint results, effect…